SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MOLE', Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.028
EU - Europa 603
AS - Asia 306
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
OC - Oceania 1
Totale 2.944
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.025
CN - Cina 216
UA - Ucraina 154
PL - Polonia 136
DE - Germania 100
TR - Turchia 86
IT - Italia 66
GB - Regno Unito 59
SE - Svezia 43
FI - Finlandia 35
RU - Federazione Russa 5
BE - Belgio 4
CA - Canada 3
EU - Europa 3
VN - Vietnam 3
BR - Brasile 1
CL - Cile 1
EC - Ecuador 1
FR - Francia 1
IR - Iran 1
NZ - Nuova Zelanda 1
Totale 2.944
Salva come PNG Salva come JPEG
Città #
Woodbridge 268
Chandler 205
Fairfield 199
Ashburn 193
Jacksonville 185
Houston 162
Warsaw 136
Ann Arbor 132
Wilmington 85
Seattle 75
Cambridge 65
Addison 52
Nanjing 44
Beijing 42
Izmir 42
Princeton 35
Boardman 32
Dearborn 25
Ferrara 25
Shanghai 21
Bremen 20
Milan 19
San Diego 17
Shenyang 17
Jinan 15
Mountain View 13
Nanchang 12
New York 10
Washington 10
Tianjin 9
Hebei 8
Jiaxing 8
Auburn Hills 7
Changsha 7
Orange 6
Indiana 5
Norwalk 5
Brussels 4
Cagliari 4
Ningbo 4
Redwood City 4
Tappahannock 4
Augusta 3
Chengdu 3
Dong Ket 3
Falls Church 3
Guangzhou 3
Hefei 3
Kunming 3
Lanzhou 3
Leawood 3
Los Angeles 3
Padova 3
Taizhou 3
Bologna 2
Helsinki 2
Kingston 2
London 2
Rome 2
Taiyuan 2
Ardabil 1
Canaro 1
Changchun 1
Des Moines 1
Dongguan 1
Fuzhou 1
Haikou 1
Hangzhou 1
Harbin 1
Kilburn 1
Knoxville 1
Navegantes 1
Nürnberg 1
San Francisco 1
San Mateo 1
Southwark 1
Toronto 1
Tosagua 1
Walnut 1
Totale 2.298
Salva come PNG Salva come JPEG
Nome #
PKC COME NUOVO TARGET MOLECOLARE NEL CONTROLLO DELLA PROLIFERAZIONE CELLULARE DEI TUMORI NEUROENDOCRINI 161
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 156
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 127
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 121
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 120
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 114
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells. 113
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 112
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 112
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 111
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 107
Growth hormone excess promotes breast cancer chemoresistance 103
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 102
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 102
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 89
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 79
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 76
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 72
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 71
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 71
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 70
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 69
Mitotane reduces the chemoresistance phenotype in an adrenocortical carcinoma cell line 66
ctivation of EGFR promotes ACC cell proliferation by inducing VEGF autocrine secretion 66
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 65
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 65
Targeting PKC in human pancreatic neuroendocrine tumor cells 64
mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures 64
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 62
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 57
miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta 53
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 51
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 47
null 40
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  16
Totale 2.974
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.611
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.611
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019195 0 0 0 0 0 0 0 0 0 0 69 126
2019/2020649 99 21 23 95 39 86 53 64 47 82 28 12
2020/2021416 39 33 16 74 9 50 10 53 5 51 60 16
2021/2022313 13 28 15 3 13 18 10 8 8 34 43 120
2022/2023422 39 39 20 55 77 52 19 36 57 0 15 13
2023/2024212 21 22 11 9 16 41 9 77 3 3 0 0
Totale 2.974